CLINICAL TRIALS PROFILE FOR CHOLETEC
✉ Email this page to a colleague
All Clinical Trials for CHOLETEC
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02235233 ↗ | Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin | Completed | National Institute of General Medical Sciences (NIGMS) | Phase 1 | 2015-04-01 | This study is designed to investigate the effect of NASH (non-alcoholic steatohepatitis) on the disposition of 99mTechnetium(Tc)-mebrofenin and to relate changes in 99mTc-mebrofenin disposition to differences in the bile acid profile and Fibroscan Fibrosis Score of healthy subjects compared to patients with NASH. |
NCT02235233 ↗ | Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin | Completed | University of North Carolina, Chapel Hill | Phase 1 | 2015-04-01 | This study is designed to investigate the effect of NASH (non-alcoholic steatohepatitis) on the disposition of 99mTechnetium(Tc)-mebrofenin and to relate changes in 99mTc-mebrofenin disposition to differences in the bile acid profile and Fibroscan Fibrosis Score of healthy subjects compared to patients with NASH. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CHOLETEC
Condition Name
Clinical Trial Locations for CHOLETEC
Trials by Country
Clinical Trial Progress for CHOLETEC
Clinical Trial Phase
Clinical Trial Sponsors for CHOLETEC
Sponsor Name